BRIEF

on HYBRIGENICS (EPA:ALHYG)

2025 Annual Results: Aton Group

Illkirch, April 28, 2026 – The Aton Group, listed on Euronext Growth Paris, presented its annual results for 2025. Revenue reached €0.7 million, primarily generated by Inoviem Scientific, a slight increase compared to 2024. EBITDA stood at -€0.1 million, marking an improvement compared to the previous year's loss. Current operating income amounted to -€0.9 million.

The group has made strategic progress with its subsidiaries, such as B Cell Design's partnership with Logical Biological. PIMS Technology has secured €500,000 in funding from Bpifrance. The outlook remains focused on commercial expansion and generating recurring revenue.

R. H.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all HYBRIGENICS news